№ lp_2_3_46593
File format: docx
Character count: 5075
File size: 132 KB
Information on allergic conjunctivitis, its symptoms, causes, and treatment options for patients, including advice for contact lens wearers and emergency services contact details.
Year:
2023
Region / City:
Not specified
Topic:
Allergic conjunctivitis treatment
Document type:
Patient information leaflet
Author:
Ms. Alice Milligan
Target audience:
Patients suffering from allergic conjunctivitis
Approval date:
May 2023
Review date:
May 2025
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2016
Region / City:
Boulder, CO
Topic:
Medical condition, Conjunctivitis
Document Type:
Medical Guidelines
Author:
La Clinica
Target Audience:
Healthcare Providers
Date of Approval:
January 2016
Period of Validity:
N/A
Suspension of Pharmacy First Service for the Management of Bacterial Conjunctivitis by NHS Devon CCG
Year:
2021
Region / City:
Devon, United Kingdom
Topic:
Healthcare, Pharmacy Services, Bacterial Conjunctivitis
Document Type:
Announcement
Organization:
NHS Devon Clinical Commissioning Group
Author:
Rebecca Perkins, Senior Medicines Optimisation Pharmacist
Target Audience:
Healthcare Professionals, Pharmacists
Effective Period:
March 16, 2021
Date of Approval:
March 16, 2021
Date of Changes:
March 16, 2021
Type of document:
Clinical case study
Subject area:
Nursing education; health disparities; clinical assessment
Clinical setting:
All Access Health Clinic
Country context:
United States
Patient:
Mr. Reyes
Patient age:
62 years
Patient ethnicity:
Hispanic
Primary language:
Spanish
Medical conditions:
Hypertension; possible Type 2 diabetes; bacterial conjunctivitis
Medications mentioned:
Lisinopril; gentamicin sulfate ophthalmic drops; ibuprofen
Diet referenced:
DASH diet
Clinical topics:
Language barriers in healthcare; use of medical translators; medication adherence; patient education
Educational focus:
Nursing assessment and communication with non-English-speaking patients
Key symptoms described:
Eye pain; purulent eye drainage; fatigue; excessive thirst; weight loss
Clinical measurements:
Blood pressure; temperature; pulse; respiratory rate; height; weight; pain score
Care issues discussed:
Improper medication administration; absence of professional translator; incomplete clinical assessment
Year:
2023
Region / City:
Europe
Topic:
Allergen immunotherapy, allergic asthma, house dust mites
Document Type:
Clinical guideline
Organization / Institution:
European Academy of Allergy and Clinical Immunology (EAACI)
Authors:
I Agache, S Lau, CA Akdis, S Smolinska, M Bonini, O Cavkaytar, B Flood, P Gajdanowicz, K Izuhara, Ö Kalayci, R Mosges, O Palomares, N Papadopoulos, M Sokolowska, E Angier, M Fernandez-Rivas, G Pajno, O Pfaar, G Roberts, D Ryan, G Sturm, R van Ree, EM Varga, R Gerth van Wijk, JJ Yepes – Nuñez, M Jutel
Target Audience:
Healthcare professionals (doctors, researchers, allergy specialists)
Date Approved:
2023
Date of Revisions:
N/A
Title:
Severe Allergic Reaction – Anaphylaxis Protocol
Type of Document:
Medical Emergency Protocol
Subject:
Anaphylaxis Management
Setting:
School and School-Related Events
Target Population:
Children and Adults
Primary Medication:
Epinephrine
Additional Medication:
Albuterol Sulfate Inhalation Solution 0.083% (2.5mg/3ml)
Emergency Response:
EMS (911) Activation Required
Monitoring Requirements:
Heart Rate, Respiratory Status, pO2, Level of Consciousness
Equipment Referenced:
AED, Portable Oxygen, Ambu Bag, Pulse Oximeter, Nebulizer
Approval Authority:
Physician
Effective Date:
Not Specified
Issuing Entity:
School/District
Documentation Required:
Incident Report and Nursing Documentation
Year:
2021
Region / city:
United States
Topic:
Anaphylaxis, Epinephrine Auto-Injector, Emergency Action Plan
Document Type:
Procedure
Organization / Institution:
School, Healthcare Providers
Author:
Bingemann, T.A., Nanda, A., Russell, A.F., Butler, S.M., Boucher, E.A., Tobison, J., Phan, H., Campbell, R.L., Kelso, J.M.
Target Audience:
School Nurses, School Staff, Healthcare Providers
Period of validity:
N/A
Approval Date:
N/A
Date of changes:
N/A
Note:
Contextual Description
Year:
2023
Region / city:
United Kingdom
Theme:
Healthcare, Allergies, Treatment Guidelines
Document type:
Patient Group Direction (PGD)
Organization:
NHS
Author:
Not specified
Target audience:
Healthcare professionals
Effective period:
Ongoing
Approval date:
Not specified
Modification date:
Not specified
Year:
2023
Region / City:
Beijing, China
Subject:
Allergic diseases, monoclonal antibody therapy, clinical trials
Document Type:
Supplementary data
Institution:
Capital Medical University, Department of Immunology
Authors:
Yan Chen, Wei Wang, Huihui Yuan, Yan Li, Zhe Lv, Ye Cui, Jie Liu, Sun Ying
Target Population:
Children, adolescents, and adults with allergic asthma
Trial Duration:
12–60 weeks
Primary Outcomes:
Treatment safety, efficacy, quality of life, pulmonary function, IgE levels
Sample Size Range:
19–4308 participants
Medications Studied:
Omalizumab
Study Design:
Controlled clinical trials with specific inclusion criteria for allergic asthma patients
Year:
2022
Journal:
World Journal of Clinical Cases
Manuscript Type:
Case Report
Authors:
Miao Zhang, Jia Chen, Chun-Xiao Wang, Nai-Xuan Lin, Xin Li
Affiliations:
Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine; Institute of Dermatology, Shanghai Academy of Traditional Chinese Medicine; Department of Dermatopathology, Shanghai Skin Disease Hospital, Tongji University
Corresponding Author:
Xin Li, MD, PhD
Received Date:
May 31, 2022
Revised Date:
July 9, 2022
Accepted Date:
August 23, 2022
Published Online:
2022
Keywords:
Vitamin K1, Subcutaneous injection, Adverse reactions, Herbal medicine, Polyoxyethylated castor oil, Case report guidelines
Target Audience:
Clinicians, Dermatologists, Researchers in clinical medicine
Patient Age:
50 years
Patient Condition:
Cutaneous allergic reaction to vitamin K1
Treatment:
Chinese herbal medicine, topical and intralesional steroids
Follow-up Duration:
32 months
Year:
Not specified
Region / city:
Not specified
Topic:
Seasonal Allergic Rhinitis, Treatment Guidelines
Document type:
Medical guideline
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Healthcare professionals (GPs, clinicians)
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Note:
Year
Topic:
Environmental Management, Risk Assessment
Document Type:
Procedure
Organization / Institution:
North West Biomass Limited
Target Audience:
Site Staff, Contractors
Note:
Year
Region / City:
Mumbai
Theme:
Personal Accident Insurance, Medical Expenses, Road Accident
Document Type:
Proposal Form
Organization / Institution:
The New India Assurance Company Limited
Target Audience:
Individuals, small groups under 51 members
Note:
Year
Note:
Year
Year:
2023
Region / City:
Fargo, ND
Topic:
Personal Accident / Injury Insurance
Document Type:
Form
Organization / Institution:
Essentia Health
Author:
Essentia Health
Target Audience:
Patients seeking personal injury insurance coverage
Effective Date:
N/A
Date of Approval:
N/A
Date of Changes:
N/A
Note:
Year
Theme:
Insurance
Document Type:
Accident Report
Organization / Institution:
Bureau of State Liability and Property Claims
Author:
Bureau of State Liability and Property Claims
Target Audience:
Insurance representatives, law enforcement agencies
Period of Effectiveness:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2024
Region / city:
Australian Capital Territory
Topic:
Motor Accident Injuries Insurance
Document type:
Guidelines
Organization / institution:
MAI Commission
Author:
Lisa Holmes
Target audience:
Insurers, MAI policyholders
Period of validity:
From 1 February 2025
Approval date:
4 September 2024
Accident Report Form for Marine Accidents and Incidents under the Merchant Shipping Regulations 2012
Year:
2012
Jurisdiction:
United Kingdom
Subject:
Marine accident and incident reporting
Document type:
Official reporting form
Governing regulation:
The Merchant Shipping (Accident Reporting and Investigation) Regulations 2012
Issuing body:
Marine Accident Investigation Branch
Related guidance:
Marine Guidance Note 564
Reporting authority:
Marine Accident Investigation Branch
Intended reporters:
Vessel masters, skippers, owners, managers, harbour authorities, inland waterway authorities, Maritime and Coastguard Agency
Scope:
Marine accidents, serious injuries, and marine incidents including near misses
Submission method:
Electronic form following initial telephone notification
Contact point:
MAIB accident reporting line
Geographical scope:
Maritime and inland waters under UK jurisdiction
Year:
N/A
Region / City:
N/A
Subject:
Construction Safety
Document Type:
Safety Program
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Employers, Supervisors, Employees in the Construction Industry
Effective Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Note:
Year
Theme:
Health and Safety
Document Type:
Incident Investigation Report
Target audience:
Employees, Employers, Health and Safety Representatives
Context:
A form used for documenting and investigating workplace accidents and incidents to identify contributing factors and recommend safety measures.